Stay updated on Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s footer revision/version was updated from v3.5.2 to v3.5.3, indicating a site release update without changing the displayed study details.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedRevision notes updated to add v3.5.0 and remove v3.4.3.SummaryDifference0.1%

- Check56 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check85 days agoChange DetectedA new Revision: v3.4.2 is displayed and an earlier government-funding status notice was removed. The study content, eligibility criteria, and outcome measures remain unchanged.SummaryDifference0.4%

- Check92 days agoChange DetectedAdded a government funding notice banner with links to cc.nih.gov and opm.gov. Updated the site software to Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.4%

Stay in the know with updates to Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.